FDA Revokes COVID-19 Emergency Use Authorizations for Two Diagnostic Devices

Summary

The US Food and Drug Administration (FDA) has revoked two Emergency Use Authorizations (EUAs) for COVID-19 diagnostic devices, issued to Babson Diagnostics, Inc. and Twist Bioscience Corporation, following requests from the authorization holders.